Press release
Antiemetics And Antinauseants Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Antiemetics And Antinauseants
The market for antiemetics and antinauseants is propelled by the rising incidence of cancer. Chemotherapy, considered one of the key cancer treatments, can cause side effects like chemotherapy-induced nausea and vomiting (CINV). Approximately 60%-70% of patients can prevent CINV using antiemetics. For example, The American Cancer Society, a US-based non-profit organization, estimated in April 2024 that there were approximately 609,000 cancer-related fatalities and expected 1.9 million new cancer diagnoses in the US in 2022. They anticipate about 620,000 cancer deaths, showing a slight increase in death rates by 2024. A surge in cancer incidences will enhance the demand for antiemetics and antinauseants, boosting the market's revenue.
Get Your Antiemetics And Antinauseants Market Report Here:
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report
What is the future CAGR of the antiemetics and antinauseants market, and how will it impact industry expansion?
In recent times, the market for antiemetics and antinauseants has been on a consistent growth trajectory. The market is projected to escalate from a value of $8.11 billion in 2024 to $8.45 billion in 2025, representing a compound annual growth rate (CAGR) of 4.3%. Factors contributing to this growth during the historical period include historical branding efforts, competitive market conditions, past treatment preferences, economic circumstances, global health incidents in the past, and advancements in medical research and technology.
The market for antiemetics and antinauseants is projected to experience substantial expansion in the approaching years, reaching a value of $9.7 billion in 2029 with a compound annual growth rate (CAGR) of 3.5%. This predicted growth during the forecast period can be tied to several factors such as research and development efforts, economic conditions, market competition, industry trends, shifts in disease patterns, and healthcare policies and regulations. Key trends projected for this period are an intensified focus on patient experience, evolving healthcare policies, a consumer lean towards non-invasive procedures, an increasing incidence of nausea related to chemotherapy and pregnancy, and the rise of targeted therapies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp
What new trends are reshaping the antiemetics and antinauseants market and its opportunities?
Significant players in the antiemetic and antinauseant markets are focusing on innovative product development, such as pre-prepared injectables, to improve treatment protocols and boost patient adherence. These pre-prepared solutions aim to offer immediate relief, lessening the intricacy and duration involved in conventional injection medications. For instance, in July 2024, Amneal Pharmaceuticals, a specialty pharmaceutical enterprise based in the US, introduced FOCINVEZ, the inaugural pre-prepared injectable formulation of fosaprepitant, created to combat acute and delayed nausea and vomiting linked with highly emetogenic cancer chemotherapy. This product, offered in a 150 mg/50 mL vial without Polysorbate 80, bypasses the need for reconstitution or dilution, enabling straightforward administration. FOCINVEZ has been approved for adults and pediatric patients aged six months and above, receiving a unique J-Code (J1434) for reimbursement purposes.
Which key market segments comprise the antiemetics and antinauseants market and drive its revenue growth?
The antiemetics and antinauseants market covered in this report is segmented -
1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), cannabinoi*ds, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types
2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types
3) By End Users: Hospital, Medical Center, Clinic, Research Institutes
Subsegments:
1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone
2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant
3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine
4) By cannabinoi*ds: Dronabinol, Nabilone
5) By Benzodiazepines: Lorazepam, Diazepam
6) By Anticholinergics: Scopolamine, Glycopyrrolate
7) By Steroids: Dexamethasone, Methylprednisolone
8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron
9) By Other Drug Types: Herbal Remedies, Acupressure Devices
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2441
What regions are at the forefront of antiemetics and antinauseants market expansion?
North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the leading players fueling growth in the antiemetics and antinauseants market?
Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy's Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp
What Is Covered In The Antiemetics And Antinauseants Global Market Report?
• Market Size Forecast: Examine the antiemetics and antinauseants market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the antiemetics and antinauseants market for a structured understanding.
• Key Players Overview: Analyze major players in the antiemetics and antinauseants market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the antiemetics and antinauseants market.
• Segment Contributions: Evaluate how different segments drive overall growth in the antiemetics and antinauseants market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the antiemetics and antinauseants market.
• Industry Challenges: Identify potential risks and obstacles affecting the antiemetics and antinauseants market.
• Competitive Landscape: Review strategic developments in the antiemetics and antinauseants market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antiemetics And Antinauseants Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3903142 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
